Literature DB >> 18385357

Multiple modes of transmission of giardiasis in primary schoolchildren of a rural community, Thailand.

Supawat Ratanapo1, Mathirut Mungthin, Suthipong Soontrapa, Chakri Faithed, Suradej Siripattanapipong, Ram Rangsin, Tawee Naaglor, Phunlerd Piyaraj, Paanjit Taamasri, Saovanee Leelayoova.   

Abstract

In February 2005, we conducted a cross-sectional study to determine the prevalence and the risk factors of giardiasis in 531 primary schoolchildren of a rural community, Chacheongsao province, Thailand. Using both sedimentation and flotation techniques to detect Giardia duodenalis, the prevalence of giardiasis was 6.2%. Assemblage A, subgenotype II and assemblage B, subgenotype IV were identified by PCR-RFLP of glutamate dehydrogenase gene. Our data might indicate that, in this population, only assemblage A, subgenotype II of G. duodenalis was transmitted via water. Using multivariate analysis, significant risk factors for giardiasis were children of age 5-9 years, households with > or = 3 children under the age of 12 years, low parental educational level, drinking bottled water, and living in close contact with dogs. Washing hands before meals had a protective effect. From these significant risk factors, multiple modes of transmission of G. duodenalis were suggested in this population.

Entities:  

Mesh:

Year:  2008        PMID: 18385357

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

Review 1.  Giardiasis: a review on assemblage distribution and epidemiology in India.

Authors:  Shakti Laishram; Gagandeep Kang; Sitara Swarna Rao Ajjampur
Journal:  Indian J Gastroenterol       Date:  2012-02-07

Review 2.  Zoonotic potential and molecular epidemiology of Giardia species and giardiasis.

Authors:  Yaoyu Feng; Lihua Xiao
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  High prevalences of infection with Giardia intestinalis genotype B among children in urban and rural areas of Argentina.

Authors:  N Molina; M Minvielle; S Grenóvero; C Salomón; J Basualdo
Journal:  Ann Trop Med Parasitol       Date:  2011-06

4.  Prophylactic Potential of Synbiotic (Lactobacillus casei and Inulin) in Malnourished Murine Giardiasis: an Immunological and Ultrastructural Study.

Authors:  Geeta Shukla; Anuj Sharma; Ruchika Bhatia; Mridul Sharma
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

5.  Could giardiasis be a risk factor for low zinc status in schoolchildren from northwestern Mexico? A cross-sectional study with longitudinal follow-up.

Authors:  Luis Quihui; Gloria G Morales; Rosa O Méndez; Johanna G Leyva; Julián Esparza; Mauro E Valencia
Journal:  BMC Public Health       Date:  2010-02-20       Impact factor: 3.295

6.  Lactobacillus rhamnosus GG antagonizes Giardia intestinalis induced oxidative stress and intestinal disaccharidases: an experimental study.

Authors:  Nisha Goyal; Praveen Rishi; Geeta Shukla
Journal:  World J Microbiol Biotechnol       Date:  2013-01-30       Impact factor: 3.312

7.  Probiotic Lactobacillus rhamnosus GG modulates the mucosal immune response in Giardia intestinalis-infected BALB/c mice.

Authors:  Nisha Goyal; Geeta Shukla
Journal:  Dig Dis Sci       Date:  2012-12-21       Impact factor: 3.199

8.  Evaluation of alpha-tubulin as an antigenic and molecular probe to detect Giardia lamblia.

Authors:  Juri Kim; Myeong Heon Shin; Kyoung-Ju Song; Soon-Jung Park
Journal:  Korean J Parasitol       Date:  2009-08-28       Impact factor: 1.341

Review 9.  A systematic review and meta-analysis of the association between Giardia lamblia and endemic pediatric diarrhea in developing countries.

Authors:  Khitam Muhsen; Myron M Levine
Journal:  Clin Infect Dis       Date:  2012-12       Impact factor: 9.079

Review 10.  Probiotics in the management of Giardia duodenalis: an update on potential mechanisms and outcomes.

Authors:  Nasrin Dashti; Mitra Zarebavani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-29       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.